Oct 01, 2019
Mazda Unveils Mazda3 TCR
Aug 14, 2019
MiLaboratories And MIODx Collaborate On Services And Product Development In TCR And BCR Repertoire Profiling
Apr 01, 2019
TCR2 Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 28, 2019
TCR2 Therapeutics Presents Preclinical Data on its Lead Solid Tumor and Blood Cancer Programs at the American Association for Cancer Research (AACR) Annual Meeting
Dec 20, 2018
North Carolina Mobile Phone Repair Company Launches New "Share the Love: Give $5, Get $5" Customer Referral Program
Nov 29, 2018
TCR2 Therapeutics wins U.S. Private Company of the Year Award at LifeStars Awards(TM) Life Sciences 2018 Event
Jul 23, 2018
GigaMune Secures Collaboration with Mass General for Development of Cell Therapies for Cancer
Jun 06, 2018
TCR Engineered T-Cell Therapy Market Report 2018: Technologies, Pipeline, Manufacturing, Companies, Financing & Outlook
May 14, 2018
TCR2 Therapeutics to Present at the UBS Global Healthcare Conference and the Jefferies 2018 Global Healthcare Conference
Apr 12, 2018
TCR2 Therapeutics to Present New Preclinical Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting
Apr 10, 2018
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
Feb 05, 2018
TCR2 Therapeutics to Present at the 2018 Keystone Symposia Conference on Emerging Cellular Therapies: T Cells and Beyond
Jan 03, 2018
TCR2 Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Nov 02, 2017
TCR2 Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board
Oct 31, 2017
TCR2 Therapeutics to Present New Data from its TRuC(TM) T Cell Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Aug 29, 2017
TCR2 Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
Aug 08, 2017
TCR2 Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference
Jun 13, 2017
TCR(2) Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC(TM) Engineered T Cell Therapies at the World Preclinical Congress